M., Toop, L., Sluyter, J., Murphy, J., Khaw, K
Zero human pregnancy safety data exists for BPC-157
Not every peptide program is appropriate for every patient
BPC-157 Essential for gut healing, as intestinal permeability and dysbiosis are common in metabolic disease states and contribute to systemic inflammation, brain fog, and fatigue through the gut-brain axis
Additionally, the weight loss was superior compared with what adults achieved with semaglutide 2.4 mg alone (Wegovy, Novo Nordisk) or cagrilintide 2.4 mg alone (Novo Nordisk)
A result from one formulation cannot automatically be applied to a different product, concentration, route, or treatment goal